Mikhail Kosiborod

Mikhail Kosiborod

Cardiologist

Saint Luke’s Mid America Heart Institute, Kansas City, US

Biography

Dr Mikhail Kosiborod is a cardiologist, the Vice President of Research at Saint Luke's Health System, and Professor of Medicine at the University of Missouri-Kansas City, US.

He is also Director of Cardiometabolic Research and Co-Director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence at Saint Luke's Mid America Heart Institute. Dr Kosiborod is an internationally-recognised expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes.

Dr Kosiborod is involved in the leadership of numerous clinical trials and multi-center registries, and is currently the principal investigator of several investigator-initiated, multi-center trials in diabetes and cardiovascular disease.

Read more

Media

ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod,

Watch time: 13m 24s

Mikhail Kosiborod, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 49m 50s (8 videos)

Mikhail Kosiborod, Shelley Zieroth,

Watch time: 19m 6s (3 videos)
Heart Failure in Focus - Ep 5

Muthiah Vaduganathan, Mikhail Kosiborod,

Listen time: 23m 6s

Andrew JS Coats, Mikhail Kosiborod,

Watch time: 17m 31s (3 videos)
Masterclass: Evidence on the Use of SGLT2is in HF Across the EF Spectrum

Scott Solomon, Harriette Van Spall, Mikhail Kosiborod, et al

Watch time: 29m 37s

Biykem Bozkurt, Andrew JS Coats, Mikhail Kosiborod, et al

Watch time: 51m 41s (3 videos)
HF 22: 2022 Heart Failure Highlights with Dr Kosiborod

Mikhail Kosiborod,

Watch time: 4m 5s

Mikhail Kosiborod, Joanna Osmanska, Cecilia Linde, et al

Watch time: 46m 15s (12 videos)
HF 22: Findings from the Pooled Analysis of DEFINE-HF and PRESERVED-HF

Mikhail Kosiborod,

Watch time: 6m 12s

Shelley Zieroth, Andrew JS Coats, Javed Butler, et al

Watch time: 10h 52m 24s (14 videos)

Giuseppe Rosano, Mikhail Kosiborod, Biykem Bozkurt, et al

Watch time: 18m 38s (3 videos)
ACC/AHA/HFSA Guideline for the Management of Heart Failure

Mikhail Kosiborod, Harriette Van Spall,

Watch time: 3m 14s
ACC 22: Results From the EMPULSE Study

Mikhail Kosiborod,

Watch time: 5m 35s
Incretin Management in Type 2 Diabetes

Mikhail Kosiborod, Silvio Inzucchi, Kamlesh Khunti, et al

The PRESERVED-HF Study – Main Study Presentation and Peer-to-peer Discussion

Mikhail Kosiborod, Dalane W Kitzman,

Watch time: 36m 12s (5 videos)
The PRESERVED-HF Study

Mikhail Kosiborod,

Watch time: 12m 4s

Federico M Asch, Jan Belohlavek, Rupert Bauersachs, et al

Watch time: 4h 24m 8s (20 videos)
ACC 2021: The DARE-19 Randomized Trial

Mikhail Kosiborod,

Watch time: 15m 45s
thumbnail

Mikhail Kosiborod, Arun Sanyal ,

Watch time: 10m 33s
thumbnail

Mikhail Kosiborod, Arun Sanyal ,

Watch time: 20m 54s
End of Year COVID update with Dr Mikhail Kosiborod and Dr Shelley Zieroth

Mikhail Kosiborod, Shelley Zieroth,

Watch time: 23m 27s
Year End Video With Dr Mikhail Kosiborod And Dr Silvio Inzucchi

Mikhail Kosiborod, Silvio Inzucchi,

Watch time: 29m 18s

Mikhail Kosiborod, Mark Petrie,

Watch time: 31m 36s (3 videos)
DAPA-HF Background Therapy

Mikhail Kosiborod, Mark Petrie,

AHA 2019: Updates from the DAPA-HF trial — Dr Harriette Van Spall and Dr Mikhail N Kosiborod

Harriette Van Spall, Mikhail Kosiborod,

Watch time: 7m 44s

Andrew JS Coats, Carolyn Lam, Felipe Martínez, et al

Watch time: 57m 59s (6 videos)
EASD 2019: The DEFINE-HF trial - Dr Mikhail N Kosiborod

Mikhail Kosiborod,

Watch time: 7m 49s
DAPA-HF: A discussion with the trialist

John JV McMurray, Mikhail Kosiborod,

Watch time: 19m 18s
ACC 2018: SGLT-2 Inhibitors Versus Other Glucose Lowering Drugs

Mikhail Kosiborod,

Watch time: 10m 16s